A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies
Clinical trial NCT02232646 · WITHDRAWN
Trial details
- NCT number
- NCT02232646
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.